{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:13:20Z","timestamp":1790619200271,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Health Science and Technology Plan Project","award":["2022KY670"],"award-info":[{"award-number":["2022KY670"]}]},{"name":"Zhejiang Province Basic Public Welfare Plan Project","award":["(LBY21H160001)"],"award-info":[{"award-number":["(LBY21H160001)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02420-x","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T03:01:52Z","timestamp":1741575712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["LncRNA-MALAT1 promotes triple-negative breast cancer progression and function as ceRNA to target REEP5 by sponging miR-106a-5p"],"prefix":"10.1186","volume":"30","author":[{"given":"Qiu-hui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-qin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-liang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-fei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"2420_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2420_CR2","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/s41598-021-81538-4","volume":"11","author":"M Rossing","year":"2021","unstructured":"Rossing M, et al. Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status. Sci Rep. 2021;11(1):2259.","journal-title":"Sci Rep"},{"key":"2420_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"2420_CR4","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1038\/s41467-022-35059-x","volume":"13","author":"A Verma","year":"2022","unstructured":"Verma A, et al. EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis. Nat Commun. 2022;13(1):7344.","journal-title":"Nat Commun"},{"issue":"8","key":"2420_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1631\/jzus.B2200113","volume":"23","author":"S Vtorushin","year":"2022","unstructured":"Vtorushin S, Dulesova A, Krakhmal N. Luminal androgen receptor (LAR) subtype of triple-negative breast cancer: molecular, morphological, and clinical features. J Zhejiang Univ Sci B. 2022;23(8):617\u201324.","journal-title":"J Zhejiang Univ Sci B"},{"key":"2420_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216508","volume":"581","author":"S Wu","year":"2024","unstructured":"Wu S, et al. A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer. Cancer Lett. 2024;581: 216508.","journal-title":"Cancer Lett"},{"issue":"3","key":"2420_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1148\/radiol.2020192534","volume":"295","author":"JM Chang","year":"2020","unstructured":"Chang JM, et al. Axillary nodal evaluation in breast cancer: state of the art. Radiology. 2020;295(3):500\u201315.","journal-title":"Radiology"},{"issue":"9","key":"2420_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1631\/jzus.B1900709","volume":"21","author":"J Xu","year":"2020","unstructured":"Xu J, et al. Roles of miRNA and lncRNA in triple-negative breast cancer. J Zhejiang Univ Sci B. 2020;21(9):673\u201389.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"2","key":"2420_CR9","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202009045","volume":"220","author":"MC Bridges","year":"2021","unstructured":"Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2): e202009045.","journal-title":"J Cell Biol"},{"issue":"8","key":"2420_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41576-024-00693-2","volume":"25","author":"M Coan","year":"2024","unstructured":"Coan M, et al. Targeting and engineering long non-coding RNAs for cancer therapy. Nat Rev Genet. 2024;25(8):578\u201395.","journal-title":"Nat Rev Genet"},{"key":"2420_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114698","volume":"162","author":"S Yang","year":"2023","unstructured":"Yang S, et al. ncRNA-mediated ceRNA regulatory network: transcriptomic insights into breast cancer progression and treatment strategies. Biomed Pharmacother. 2023;162: 114698.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2420_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbrc.2020.01.170","volume":"526","author":"R Wang","year":"2020","unstructured":"Wang R, et al. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p\/TOB1 axis. Biochem Biophys Res Commun. 2020;526(4):1005\u201312.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2420_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13000-021-01105-3","volume":"16","author":"J Sun","year":"2021","unstructured":"Sun J, et al. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p\/SOX17\/\u03b2-catenin axis in triple-negative breast cancer. Diagn Pathol. 2021;16(1):45.","journal-title":"Diagn Pathol"},{"issue":"12","key":"2420_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1631\/jzus.B2300067","volume":"24","author":"Q Yang","year":"2023","unstructured":"Yang Q, et al. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer. J Zhejiang Univ Sci B. 2023;24(12):1123\u201340.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"1","key":"2420_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-024-02081-0","volume":"23","author":"M Bayat","year":"2024","unstructured":"Bayat M, Sadri Nahand J. Exosomal miRNAs: the tumor\u2019s Trojan horse in selective metastasis. Mol Cancer. 2024;23(1):167.","journal-title":"Mol Cancer"},{"issue":"1","key":"2420_CR16","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1186\/s12885-024-12893-4","volume":"24","author":"S Liu","year":"2024","unstructured":"Liu S, et al. Ethoxy-erianin phosphate inhibits angiogenesis in colorectal cancer by regulating the TMPO-AS1\/miR-126-3p\/PIK3R2 axis and inactivating the PI3k\/AKT signaling pathway. BMC Cancer. 2024;24(1):1275.","journal-title":"BMC Cancer"},{"issue":"4","key":"2420_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10585-022-10165-8","volume":"39","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Zhu K, Wang G. miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6. Clin Exp Metastasis. 2022;39(4):603\u201321.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"2420_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13046-024-03204-7","volume":"43","author":"Y Liang","year":"2024","unstructured":"Liang Y, et al. Exosomal miR-106a-5p from highly metastatic colorectal cancer cells drives liver metastasis by inducing macrophage M2 polarization in the tumor microenvironment. J Exp Clin Cancer Res. 2024;43(1):281.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"2420_CR19","doi-asserted-by":"publisher","first-page":"8115","DOI":"10.18632\/aging.202608","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang H, et al. Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p\/STAT3 axis in breast cancer. Aging (Albany NY). 2021;13(6):8115\u201326.","journal-title":"Aging (Albany NY)"},{"key":"2420_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106477","volume":"185","author":"S Fan","year":"2022","unstructured":"Fan S, Liu H, Li L. The REEP family of proteins: Molecular targets and role in pathophysiology. Pharmacol Res. 2022;185: 106477.","journal-title":"Pharmacol Res"},{"issue":"5","key":"2420_CR21","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201907183","volume":"220","author":"F Chen","year":"2021","unstructured":"Chen F, et al. FIT2 organizes lipid droplet biogenesis with ER tubule-forming proteins and septins. J Cell Biol. 2021;220(5): e201907183.","journal-title":"J Cell Biol"},{"issue":"3","key":"2420_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007205","volume":"7","author":"L Yao","year":"2018","unstructured":"Yao L, et al. REEP5 (Receptor Accessory Protein 5) acts as a sarcoplasmic reticulum membrane sculptor to modulate cardiac function. J Am Heart Assoc. 2018;7(3): e007205.","journal-title":"J Am Heart Assoc"},{"key":"2420_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115011","volume":"199","author":"H Mao","year":"2022","unstructured":"Mao H, et al. Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseases. Biochem Pharmacol. 2022;199: 115011.","journal-title":"Biochem Pharmacol"},{"key":"2420_CR24","doi-asserted-by":"publisher","first-page":"39041","DOI":"10.1038\/srep39041","volume":"6","author":"CR Park","year":"2016","unstructured":"Park CR, et al. The accessory proteins REEP5 and REEP6 refine CXCR1-mediated cellular responses and lung cancer progression. Sci Rep. 2016;6:39041.","journal-title":"Sci Rep"},{"issue":"14","key":"2420_CR25","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/1535370218813909","volume":"243","author":"F Isyraqiah","year":"2018","unstructured":"Isyraqiah F, et al. Leptin induces the expression of tumorigenic genes in the gastric mucosa of male Sprague-Dawley rats. Exp Biol Med (Maywood). 2018;243(14):1118\u201324.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"2420_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/cancers12040916","volume":"12","author":"E Vagia","year":"2020","unstructured":"Vagia E, Mahalingam D, Cristofanilli M. The landscape of targeted therapies in TNBC. Cancers (Basel). 2020;12(4):916.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"2420_CR27","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1631\/jzus.B2100393","volume":"22","author":"B Wang","year":"2021","unstructured":"Wang B, et al. ER\u03b1 promotes transcription of tumor suppressor gene ApoA-I by establishing H3K27ac-enriched chromatin microenvironment in breast cancer cells. J Zhejiang Univ Sci B. 2021;22(12):1034\u201344.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"15 Pt 1","key":"2420_CR28","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429\u201334.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2420_CR29","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/ijc.32270","volume":"145","author":"JJ Arroyo-Crespo","year":"2019","unstructured":"Arroyo-Crespo JJ, et al. Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression. Int J Cancer. 2019;145(8):2267\u201381.","journal-title":"Int J Cancer"},{"issue":"1","key":"2420_CR30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41467-020-14802-2","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers. Nat Commun. 2020;11(1):1000.","journal-title":"Nat Commun"},{"issue":"4","key":"2420_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccell.2019.01.019","volume":"35","author":"R Esposito","year":"2019","unstructured":"Esposito R, et al. Hacking the Cancer Genome: profiling therapeutically actionable long non-coding RNAs using CRISPR-Cas9 screening. Cancer Cell. 2019;35(4):545\u201357.","journal-title":"Cancer Cell"},{"issue":"5","key":"2420_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272\u201383.","journal-title":"Nat Rev Genet"},{"key":"2420_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114672","volume":"162","author":"B Ma","year":"2023","unstructured":"Ma B, et al. Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research. Biomed Pharmacother. 2023;162: 114672.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2420_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.32604\/or.2023.046582","volume":"32","author":"X Huang","year":"2023","unstructured":"Huang X, et al. Circular RNAs in breast cancer diagnosis, treatment and prognosis. Oncol Res. 2023;32(2):241\u20139.","journal-title":"Oncol Res"},{"issue":"9","key":"2420_CR35","doi-asserted-by":"publisher","first-page":"14465","DOI":"10.1002\/jcb.28706","volume":"120","author":"J Wu","year":"2019","unstructured":"Wu J, Li M, Zhang Y. Long noncoding RNA HOXA-AS2 regulates the expression of SCN3A by sponging miR-106a in breast cancer. J Cell Biochem. 2019;120(9):14465\u201375.","journal-title":"J Cell Biochem"},{"key":"2420_CR36","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/carcin\/bgad053","volume":"4","author":"H Yan","year":"2023","unstructured":"Yan H, et al. MALAT1 regulates network of microRNA-15a\/16-VEGFA to promote tumorigenesis and angiogenesis in multiple myeloma. Carcinogenesis. 2023;4:760\u201372.","journal-title":"Carcinogenesis"},{"key":"2420_CR37","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.biopha.2017.09.005","volume":"95","author":"Y Zuo","year":"2017","unstructured":"Zuo Y, et al. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. Biomed Pharmacother. 2017;95:922\u20138.","journal-title":"Biomed Pharmacother"},{"key":"2420_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2020.12.025","volume":"75","author":"T Kim","year":"2021","unstructured":"Kim T, Croce CM. MicroRNA and ER stress in cancer. Semin Cancer Biol. 2021;75:3\u201314.","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"2420_CR39","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/cancers13071493","volume":"13","author":"CMS Silva","year":"2021","unstructured":"Silva CMS, et al. Circulating let-7e-5p, miR-106a-5p, miR-28\u20133p, and miR-542\u20135p as a promising microRNA signature for the detection of colorectal cancer. Cancers (Basel). 2021;13(7):1493.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2420_CR40","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1080\/21655979.2021.1960774","volume":"12","author":"P Du","year":"2021","unstructured":"Du P, et al. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3\/HIF-1\u03b1 pathway. Bioengineered. 2021;12(1):5028\u201344.","journal-title":"Bioengineered"},{"issue":"1","key":"2420_CR41","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41467-019-14143-9","volume":"11","author":"SH Lee","year":"2020","unstructured":"Lee SH, et al. REEP5 depletion causes sarco-endoplasmic reticulum vacuolization and cardiac functional defects. Nat Commun. 2020;11(1):965.","journal-title":"Nat Commun"},{"issue":"1","key":"2420_CR42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41467-020-20625-y","volume":"12","author":"N Wang","year":"2021","unstructured":"Wang N, et al. Mechanism of membrane-curvature generation by ER-tubule shaping proteins. Nat Commun. 2021;12(1):568.","journal-title":"Nat Commun"},{"key":"2420_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102001","volume":"67","author":"F Yang","year":"2021","unstructured":"Yang F, et al. CXCR1 correlates to poor outcomes of EGFR-TKI against advanced non-small cell lung cancer by activating chemokine and JAK\/STAT pathway. Pulm Pharmacol Ther. 2021;67: 102001.","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"2420_CR44","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1158\/1078-0432.CCR-12-1063","volume":"19","author":"JK Singh","year":"2013","unstructured":"Singh JK, et al. Targeting CXCR1\/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms. Clin Cancer Res. 2013;19(3):643\u201356.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2420_CR45","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.7150\/thno.15625","volume":"7","author":"H Ha","year":"2017","unstructured":"Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases. Theranostics. 2017;7(6):1543\u201388.","journal-title":"Theranostics"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02420-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T03:15:32Z","timestamp":1741576532000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02420-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2420"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02420-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Zhejiang Cancer Hospital (Ethics Number: IRB-2022-143). Additional informed consent was obtained from all patients for which identifying information is included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}